The MTR gene helps your body use vitamin B12 to turn homocysteine into methionine, a step needed for healthy nerves, red blood cells, and DNA. This gene plays an important role in keeping methylation, your cells’ chemical control system, working normally. If the gene does not work well, homocysteine can build up and methionine can fall, which may lead to anemia, developmental delay, nerve problems, and other features of a rare inherited condition.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or manage processes in the body. Some genes carry the code for proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
MTRGene function
What if the gene works
The MTR gene helps your body use folate and vitamin B12 to turn homocysteine into methionine. This supports DNA production and other chemical tagging steps that help cells work normally.
Risk
What if the gene does not work
Pathogenic variants in the MTR gene can cause cblG disease, with high homocysteine, megaloblastic anemia, and neurologic or developmental problems. Milder variants may have smaller effects, while more severe variants often lead to earlier symptoms and a range of features.
Treatment
What does that mean for your treatment
Pathogenic variants in the MTR gene are managed with metabolic treatment centered on parenteral hydroxocobalamin, often with betaine, and care is adjusted to symptoms and lab results. Nitrous oxide is usually avoided because it can further block methionine synthase and worsen the metabolic imbalance.
Conditions associated with MTR
Gene function
What if the gene works
Your cells use the MTR gene every day to recycle nutrients and keep essential chemical pathways moving. It helps convert homocysteine into methionine, an amino acid your body uses to build proteins and make other important molecules. This step also links folate and vitamin B12 in a practical way. Understanding the MTR gene’s function helps you see how cells support steady growth and repair over time.
The MTR gene helps your cells turn homocysteine into methionine. This gives the body a steady supply of methionine, an amino acid used to make proteins and other key compounds.
Instead of letting homocysteine sit unused, this gene helps recycle it into a useful building block. That everyday step is a major part of how the MTR gene helps process homocysteine and methionine in human cells.
By making methionine, the MTR gene supports methylation, a system that adds small chemical tags to DNA, proteins, and other molecules. These tags help cells control gene activity and routine cell tasks.
This gene lets folate and vitamin B12 work together during an important recycling step. That connection helps cells use nutrients efficiently as they grow, divide, and maintain tissues.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and form part of normal human diversity, including variations in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MTR gene can make methionine synthase fold poorly, become unstable, bind vitamin B12 less well, or work less efficiently. In many cases, MTR gene variants affect enzyme activity by altering key parts of the protein or disrupting splicing, which can produce a shortened protein. Milder variants may leave some activity, while more severe loss-of-function variants can nearly eliminate it and may be linked to earlier symptoms.
How variants are linked to conditions
Pathogenic variants in the MTR gene cause cblG type methylcobalamin deficiency, a rare inherited condition also known as homocystinuria with megaloblastic anemia, cblG type. This condition linked to the MTR gene usually appears when a person inherits two pathogenic variants, and genetic results can confirm the diagnosis. People may develop anemia, developmental delay, seizures, or vision and nerve problems.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the MTR gene itself. In general, folate and vitamin B12 levels can affect the body pathway this gene is involved in, but that does not mean they change gene-related risk in a clear, proven way.
Inheritance of MTR variants
For families looking up how MTR gene variants are inherited, the well-established pattern for MTR-related cblG disease is autosomal recessive. This means a child inherits one MTR variant from each parent. Parents who carry one variant are usually healthy carriers. When both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child who did not inherit either variant.
What does my MTR result mean for my family?
For MTR, family implications are usually discussed in the context of a rare inherited condition passed down in a recessive way. This often means parents are healthy carriers, brothers and sisters may also be affected or be carriers, and close relatives may want to learn whether the same gene change runs in the family. Children of someone with an MTR-related condition will usually be carriers unless the other parent also carries an MTR change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry an MTR gene variant, MTR gene variant testing reads DNA from a blood or saliva sample and looks for changes in the MTR gene. Results may show a known variant, no variant, or a change whose health meaning is still being clarified.
When should I consider getting a genetic test?
Consider genetic testing for the MTR gene if you or your child has signs of this rare inherited condition, such as anemia, developmental delay, seizures, or blood tests showing a buildup of homocysteine, a body chemical. Testing may also make sense when a close family member has an MTR gene change or an MTR-related condition.
A genetic result is only one part of your health story
Genetic findings can be meaningful, but how much they reveal varies based on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This is common and can influence how well a medicine works or the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medication. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. If you want to read more about this topic, more detail is available in the LearnHub.
Drugs influenced by the MTR gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general concerns about side effects, supplements, or how a medicine is working are best discussed with your doctor. MTR has been studied in research on folate-related medicines, but those findings are not used as standard treatment guidance.
History
In recent decades, awareness of this gene’s role has grown through research on folate, vitamin B12, and homocysteine metabolism. The MTR gene was identified as the gene for methionine synthase, an enzyme that had already been studied in biochemistry before the gene itself was mapped and sequenced. In the 1990s and early 2000s, researchers linked variants in the MTR gene to inherited problems affecting homocysteine levels and the body’s use of folate and vitamin B12. From these first observations, research expanded steadily into newborn metabolic conditions, pregnancy related folate pathways, and population studies of common variants. Over time, scientists’ understanding of the gene’s function has changed as genetic testing made it easier to connect laboratory findings with patterns seen in families.